Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand.
Price History & Performance
|Historical stock prices|
|Current Share Price||NZ$1.28|
|52 Week High||NZ$1.02|
|52 Week Low||NZ$1.28|
|1 Month Change||10.35%|
|3 Month Change||8.48%|
|1 Year Change||24.27%|
|3 Year Change||-4.48%|
|5 Year Change||-52.59%|
|Change since IPO||166.67%|
Recent News & Updates
Capital Allocation Trends At Green Cross Health (NZSE:GXH) Aren't Ideal
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Green Cross Health (NZSE:GXH) Share Prices Have Dropped 58% In The Last Five Years
The main aim of stock picking is to find the market-beating stocks. But even the best stock picker will only win with...
Is Green Cross Health Limited (NZSE:GXH) Popular Amongst Insiders?
The big shareholder groups in Green Cross Health Limited ( NZSE:GXH ) have power over the company. Large companies...
Has Green Cross Health (NZSE:GXH) Got What It Takes To Become A Multi-Bagger?
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
|GXH||NZ Consumer Retailing||NZ Market|
Return vs Industry: GXH exceeded the NZ Consumer Retailing industry which returned 3.5% over the past year.
Return vs Market: GXH exceeded the NZ Market which returned 2.2% over the past year.
Stable Share Price: GXH is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: GXH's weekly volatility (4%) has been stable over the past year.
About the Company
Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand. It operates in three segments: Pharmacy Services, Medical Services, and Community Health. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores.
Green Cross Health Fundamentals Summary
|GXH fundamental statistics|
Is GXH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|GXH income statement (TTM)|
|Cost of Revenue||NZ$510.86m|
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.12|
|Net Profit Margin||2.94%|
How did GXH perform over the long term?See historical performance and comparison
Is Green Cross Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GXH (NZ$1.28) is trading below our estimate of fair value (NZ$20.09)
Significantly Below Fair Value: GXH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GXH is good value based on its PE Ratio (10.9x) compared to the Oceanic Consumer Retailing industry average (25.7x).
PE vs Market: GXH is good value based on its PE Ratio (10.9x) compared to the NZ market (22.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate GXH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: GXH is good value based on its PB Ratio (1.3x) compared to the XO Consumer Retailing industry average (3.7x).
How is Green Cross Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Consumer Retailing industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Green Cross Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Green Cross Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GXH has high quality earnings.
Growing Profit Margin: GXH's current net profit margins (2.9%) are higher than last year (2.4%).
Past Earnings Growth Analysis
Earnings Trend: GXH's earnings have declined by 5.1% per year over the past 5 years.
Accelerating Growth: GXH's earnings growth over the past year (24.2%) exceeds its 5-year average (-5.1% per year).
Earnings vs Industry: GXH earnings growth over the past year (24.2%) exceeded the Consumer Retailing industry 13.2%.
Return on Equity
High ROE: GXH's Return on Equity (14.1%) is considered low.
How is Green Cross Health's financial position?
Financial Position Analysis
Short Term Liabilities: GXH's short term assets (NZ$108.5M) do not cover its short term liabilities (NZ$121.8M).
Long Term Liabilities: GXH's short term assets (NZ$108.5M) exceed its long term liabilities (NZ$93.5M).
Debt to Equity History and Analysis
Debt Level: GXH's debt to equity ratio (16.3%) is considered satisfactory.
Reducing Debt: GXH's debt to equity ratio has reduced from 76.8% to 16.3% over the past 5 years.
Debt Coverage: GXH's debt is well covered by operating cash flow (291%).
Interest Coverage: GXH's interest payments on its debt are well covered by EBIT (5.5x coverage).
What is Green Cross Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate GXH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GXH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GXH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GXH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: GXH is not paying a notable dividend for the NZ market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GXH's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ms. Rachael Newfield has been the Group Chief Executive Officer of Green Cross Health Limited since January 2019.
Experienced Management: GXH's management team is considered experienced (3.2 years average tenure).
Experienced Board: GXH's board of directors are considered experienced (9.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Green Cross Health Limited's employee growth, exchange listings and data sources
- Name: Green Cross Health Limited
- Ticker: GXH
- Exchange: NZSE
- Founded: 1999
- Industry: Drug Retail
- Sector: Consumer Retailing
- Market Cap: NZ$183.236m
- Shares outstanding: 143.15m
- Website: https://www.greencrosshealth.co.nz
Number of Employees
- Green Cross Health Limited
- Building B
- Ground Floor
- New Zealand
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/17 06:02|
|End of Day Share Price||2021/10/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.